OptimiTM-03.jpg
Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing
05 sept. 2023 07h30 HE | Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation...
headshots-jj-wilson-optimi-3
Optimi Health Announces CAD $3,000,000 Senior Debt Financing
10 août 2023 07h30 HE | Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian drug research and formulation company licensed by Health Canada...
OptimiTM-03.jpg
Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent
01 août 2023 07h30 HE | Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits
17 juil. 2023 09h51 HE | Institute of Biomedical Research Corp.
CAPE TOWN, South Africa, July 17, 2023 (GLOBE NEWSWIRE) -- via IBN -- Institute of Biomedical Research Corp. (OTC PINK: MRES) (“Institute of Biomedical Research” or the "Company"), a nutraceutical...
PharmAla Biotech Logo 800 x 422.png
Cortexa Makes First Drug Order for Australian Commercial Market
04 juil. 2023 08h55 HE | PharmAla Biotech
VANCOUVER, British Columbia, July 04, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
OptimiTM-03.jpg
Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS
15 juin 2023 09h40 HE | Optimi Health Corp.
VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
ihl_logo.png
World Renowned International Psychedelics Experts Join Clarion Clinics Advisory Board
30 mai 2023 08h00 HE | Incannex Healthcare
Highlights: Three world-leading clinical psychedelics experts join Clarion Clinics Advisory Board.Dr. Bill Richards is among the world’s best known psychedelic researchers and practitioners. He has...
OptimiTM-03.jpg
Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market
17 mai 2023 08h15 HE | Optimi Health Corp.
VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
PharmAla Biotech Logo 800 x 422.png
PharmAla Biotech and Shaman Pharma Granted First Ever Special Access Program Authorization for MDMA
16 mai 2023 11h37 HE | PharmAla Biotech
VANCOUVER, British Columbia, May 16, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and manufacturing...
OptimiTM-03.jpg
Optimi Health Granted Natural Health Product Site Licence By Health Canada
10 mai 2023 08h45 HE | Optimi Health Corp.
VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...